AMENDMENT #3 TO TASK ORDER #13 COHERUS Project Number: CHS0214-02 MEDPACE Project Number: ETA302Coherus BioSciences, Inc. • September 25th, 2014 • Biological products, (no disgnostic substances)
Company FiledSeptember 25th, 2014 IndustryThis Amendment #3 (“Amendment #3”) to Task Order #13 effective as of 18 October 2013 (“Task Order”), is by and between Coherus Bioscience, Inc., a Delaware corporation with its principal place of business at 201 Redwood Shores Parkway, Suite 200 Redwood City, CA 94065 (“Sponsor”), and Medpace, Inc., with its principal place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 (“Medpace”). This Amendment #3 shall be effective 30 May 2014.
AMENDMENT #3 TO TASK ORDER #13 COHERUS Project Number: CHS0214-02 MEDPACE Project Number: ETA302Coherus BioSciences, Inc. • September 24th, 2014 • Biological products, (no disgnostic substances)
Company FiledSeptember 24th, 2014 IndustryThis Amendment #3 (“Amendment #3”) to Task Order #13 effective as of 18 October 2013 (“Task Order”), is by and between Coherus Bioscience, Inc., a Delaware corporation with its principal place of business at 201 Redwood Shores Parkway, Suite 200 Redwood City, CA 94065 (“Sponsor”), and Medpace, Inc., with its principal place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 (“Medpace”). This Amendment #3 shall be effective 30 May 2014.